GO:0015870 acetylcholine transport: Vesicular Storage Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015870 acetylcholine transport describes the directed movement of acetylcholine into, out of, or within a cell by transporters or pores.
• The vesicular acetylcholine transporter (VAChT, SLC18A3) is the best-characterized protein that actively packages acetylcholine into synaptic vesicles using a proton gradient.
• Acetylcholine transport is essential for cholinergic neurotransmission at neuromuscular junctions and parasympathetic synapses.
• Non-neuronal acetylcholine transport occurs in epithelial and immune cells and can influence cancer progression and inflammation.
• The organic cation transporter SLC22A4 (OCTN1) mediates acetylcholine and acetylcarnitine transport in peritoneal and other tissues.
• Dysregulated acetylcholine transport is implicated in gastric secretion disorders, lung cancer progression, and pre-metastatic niche formation.
Description
Acetylcholine transport (GO:0015870) is the biological process by which the neurotransmitter acetylcholine is moved into, out of, or within cells via transporters or pores. This process is fundamental to cholinergic signaling, enabling the storage of acetylcholine in synaptic vesicles and its subsequent release at synapses of parasympathetic nerves and neuromuscular junctions. The directed movement of acetylcholine ensures that this signaling molecule is available for rapid, regulated secretion in response to neuronal activity. Researchers study acetylcholine transport to understand synaptic transmission, neuromuscular function, and the broader roles of cholinergic signaling in non-neuronal tissues. Beyond the nervous system, acetylcholine transport has been detected in epithelial cells, immune cells, and cancer cells, where it contributes to diverse physiological and pathological processes. The vesicular acetylcholine transporter (VAChT) is the prototypical protein that actively transports acetylcholine into synaptic vesicles, a step that is essential for its storage and release. The organic cation transporter SLC22A4 (OCTN1) has also been shown to transport acetylcholine and acetylcarnitine in peritoneal and other cell types. Understanding the molecular mechanisms and regulation of acetylcholine transport is therefore critical for neurobiology, cancer research, and pharmacology.
acetylcholine transport At A Glance
| GO ID | GO:0015870 |
|---|---|
| GO term | acetylcholine transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of acetylcholine into, out of, or within a cell by transporters or pores |
| Key transporter | Vesicular acetylcholine transporter (VAChT, SLC18A3) |
| Additional transporter | SLC22A4 (OCTN1) |
| Physiological context | Cholinergic neurotransmission at neuromuscular junctions and parasympathetic synapses |
| Non-neuronal roles | Epithelial and immune cell signaling, cancer progression |
What Is GO:0015870?
According to the Gene Ontology, GO:0015870 acetylcholine transport is defined as the directed movement of acetylcholine into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Acetylcholine is an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions. This process encompasses both vesicular transport, where acetylcholine is packaged into synaptic vesicles by the vesicular acetylcholine transporter (VAChT), and plasma membrane transport mediated by other transporters such as SLC22A4. The term is a biological process and does not include the synthesis or degradation of acetylcholine, only its movement across membranes.
Why Is acetylcholine transport Important in Cell Biology?
Acetylcholine transport is essential for cholinergic neurotransmission, and its disruption leads to severe neurological and muscular disorders. The vesicular acetylcholine transporter (VAChT) is required for loading acetylcholine into synaptic vesicles, a prerequisite for its release at synapses. In non-neuronal tissues, acetylcholine transport contributes to gastric acid secretion, epithelial homeostasis, and cancer progression. Recent studies have shown that chronic stress induces pulmonary epithelial cells to produce acetylcholine, which remodels the lung pre-metastatic niche of breast cancer by enhancing NETosis. The organic cation transporter SLC22A4 (OCTN1) mediates acetylcholine transport in peritoneum, linking this process to peritoneal physiology and drug transport. Therefore, understanding acetylcholine transport is critical for developing therapies for neurodegenerative diseases, neuromuscular disorders, and cancer.
• Essential for synaptic vesicle loading and neurotransmitter release at cholinergic synapses.
• Required for neuromuscular junction function and muscle contraction.
• Mediates non-neuronal cholinergic signaling in epithelial and immune cells.
• Involved in gastric acid secretion and regulation of digestive function.
• Contributes to cancer progression, including lung cancer and breast cancer pre-metastatic niche formation.
• SLC22A4 (OCTN1) transports acetylcholine and acetylcarnitine, linking transport to metabolic and drug disposition pathways.
• Dysregulation of acetylcholine transport is implicated in neurodegenerative and neuromuscular diseases.
• Provides targets for pharmacological modulation of cholinergic signaling.
• Important for understanding choline transport and phospholipid synthesis in non-neuronal tissues.
• Enables research on vesicular storage mechanisms shared with monoamine transporters.
What Happens During acetylcholine transport?
Vesicular uptake of acetylcholine
In simple terms: Acetylcholine is pumped into tiny sacs called synaptic vesicles so it can be released later.
The vesicular acetylcholine transporter (VAChT, SLC18A3) actively transports acetylcholine from the cytoplasm into synaptic vesicles. This transport is driven by a proton gradient generated by the vacuolar H+-ATPase, which acidifies the vesicle lumen. VAChT is a member of the SLC18 family of vesicular neurotransmitter transporters and is essential for storing acetylcholine for subsequent release. The active transport of acetylcholine by human VAChT has been demonstrated in reconstituted systems, confirming its role in vesicular storage.
Plasma membrane transport of acetylcholine
In simple terms: Acetylcholine can also move across the outer cell membrane through specific transporter proteins.
In addition to vesicular transport, acetylcholine can be transported across the plasma membrane by transporters such as SLC22A4 (OCTN1). SLC22A4 mediates the transport of acetylcholine and acetylcarnitine in peritoneal cells, suggesting a role in non-neuronal cholinergic signaling. This plasma membrane transport may regulate extracellular acetylcholine levels and contribute to autocrine or paracrine signaling in epithelial and immune cells.
Release and reuptake of acetylcholine
In simple terms: After release, acetylcholine is quickly broken down, and its components are recycled.
Once synaptic vesicles fuse with the plasma membrane, acetylcholine is released into the synaptic cleft. The action of acetylcholine is terminated by acetylcholinesterase, which hydrolyzes it into choline and acetate. Choline is then taken back up into the presynaptic neuron by the high-affinity choline transporter (CHT1, SLC5A7) and reused for acetylcholine synthesis. This cycle of release and reuptake ensures efficient cholinergic neurotransmission.
Non-neuronal acetylcholine transport
In simple terms: Cells outside the nervous system also transport acetylcholine for local signaling.
Non-neuronal cells, including epithelial cells, immune cells, and cancer cells, express components of the acetylcholine transport machinery. For example, chronic stress induces pulmonary epithelial cells to produce acetylcholine, which remodels the lung pre-metastatic niche of breast cancer by enhancing NETosis. Acetylcholine signaling in lung cancers involves transport and receptor-mediated effects that promote tumor progression. These findings highlight the broader biological significance of acetylcholine transport beyond the nervous system.
Regulation of acetylcholine transport
In simple terms: The movement of acetylcholine is controlled by cellular signals and transporter availability.
Acetylcholine transport is regulated at multiple levels, including transporter expression, vesicular proton gradient, and post-translational modifications. The vesicular acetylcholine transporter (VAChT) expression is influenced by cholinergic neuronal activity and developmental cues. In non-neuronal tissues, inflammatory signals and stress can upregulate acetylcholine production and transport. The activity of SLC22A4 can be modulated by substrates and inhibitors, affecting acetylcholine transport in peritoneum and other tissues.
Key Genes Involved in GO:0015870 acetylcholine transport
The following genes and proteins are directly involved in acetylcholine transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC18A3 (VAChT) | Vesicular acetylcholine transporter; packages acetylcholine into synaptic vesicles | Target for studying vesicular storage and cholinergic neurotransmission |
| SLC22A4 (OCTN1) | Plasma membrane transporter of acetylcholine and acetylcarnitine | Linked to peritoneal transport and non-neuronal cholinergic signaling |
| SLC5A7 (CHT1) | High-affinity choline transporter; supplies choline for acetylcholine synthesis | Indirectly supports acetylcholine transport by providing substrate |
| ACHE | Acetylcholinesterase; hydrolyzes acetylcholine after release | Regulates acetylcholine availability and transport dynamics |
| CHAT | Choline acetyltransferase; synthesizes acetylcholine | Provides acetylcholine for transport and storage |
| SLC18A1 | Vesicular monoamine transporter 1; related to VAChT in storage mechanisms | Comparative studies of vesicular transport |
| SLC18A2 | Vesicular monoamine transporter 2; shares transport mechanisms with VAChT | Model for understanding vesicular neurotransmitter transport |
| ATP6V0A1 | Vacuolar H+-ATPase subunit; generates proton gradient for vesicular transport | Essential for VAChT function and vesicular acidification |
| ATP6V1A | Vacuolar H+-ATPase subunit; supports vesicular proton gradient | Required for active transport of acetylcholine into vesicles |
| SLC44A1 | Choline transporter-like protein 1; may influence choline availability | Indirect role in acetylcholine synthesis and transport |
| SLC44A2 | Choline transporter-like protein 2; involved in choline transport | Potential modifier of acetylcholine production |
| CHRNA1 | Nicotinic acetylcholine receptor subunit; responds to released acetylcholine | Downstream effector of acetylcholine transport |
| CHRNB1 | Nicotinic acetylcholine receptor subunit; mediates neuromuscular signaling | Readout for acetylcholine transport function |
| CHRM1 | Muscarinic acetylcholine receptor; mediates parasympathetic responses | Functional assay for acetylcholine release and transport |
| SLC22A5 | Organic cation/carnitine transporter; related to SLC22A4 | Comparative studies of acetylcholine transport |
| SLC22A1 | Organic cation transporter 1; potential acetylcholine transport | Candidate for non-neuronal acetylcholine transport |
| SLC22A2 | Organic cation transporter 2; potential acetylcholine transport | Candidate for non-neuronal acetylcholine transport |
| SLC22A3 | Organic cation transporter 3; potential acetylcholine transport | Candidate for non-neuronal acetylcholine transport |
How Is acetylcholine transport Regulated?
Acetylcholine transport is regulated by the expression and activity of transporters such as VAChT and SLC22A4, as well as by the proton gradient that drives vesicular uptake. The vesicular acetylcholine transporter (VAChT) is subject to transcriptional regulation by cholinergic neuronal activity and developmental signals. In non-neuronal tissues, inflammatory cytokines and stress can upregulate acetylcholine production and transport, as shown in pulmonary epithelial cells under chronic stress. The activity of SLC22A4 can be modulated by substrates, inhibitors, and possibly phosphorylation, affecting acetylcholine transport in peritoneum. Additionally, the availability of choline, provided by the high-affinity choline transporter (CHT1), indirectly regulates acetylcholine synthesis and subsequent transport.
acetylcholine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC18A3 (VAChT) | Neuromuscular disorders, reduced synaptic vesicle loading | Knockout or point-mutation cell models to assess vesicular transport |
| SLC22A4 (OCTN1) | Peritoneal transport, inflammation, drug disposition | Overexpression or knockout in peritoneal cell lines |
| CHAT | Cholinergic deficiency, gastric secretion disorders | Knockout models to study acetylcholine synthesis and transport |
| ACHE | Alzheimer's disease, neuromuscular junction disorders | Point-mutation models to alter acetylcholine hydrolysis |
| CHRNA1 | Myasthenia gravis, congenital myasthenic syndromes | Knock-in models to study receptor-transport coupling |
Acetylcholine transport in cancer progression
Acetylcholine transport and signaling are increasingly recognized as contributors to cancer progression. In lung cancers, components of the acetylcholine signaling system, including transporters and receptors, promote tumor cell proliferation and survival. Chronic stress induces pulmonary epithelial cells to produce acetylcholine, which remodels the lung pre-metastatic niche of breast cancer by enhancing NETosis. These findings suggest that targeting acetylcholine transport could be a therapeutic strategy in cancer.
Acetylcholine transport in gastric secretion
Acetylcholine transport is essential for gastric acid secretion, as vagal stimulation releases acetylcholine that acts on parietal cells. The transport of acetylcholine into synaptic vesicles and its release at parasympathetic synapses are critical for regulating gastric function. Disruptions in acetylcholine transport can lead to gastric secretion disorders.
Acetylcholine transport in neuromuscular and neurodegenerative disorders
Defects in acetylcholine transport can impair neuromuscular transmission and contribute to neurodegenerative diseases. The vesicular acetylcholine transporter (VAChT) is required for loading acetylcholine into synaptic vesicles, and its dysfunction leads to reduced neurotransmitter release. Understanding these mechanisms is important for developing treatments for myasthenia gravis and Alzheimer's disease.
From acetylcholine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does VAChT mediate vesicular acetylcholine transport? | SLC18A3 knockout cell line with vesicular transport assay |
| What is the role of SLC22A4 in acetylcholine transport? | SLC22A4 overexpression and knockout in peritoneal cells |
| How does chronic stress affect acetylcholine transport in lung epithelium? | Stress-induced pulmonary epithelial cell models with acetylcholine measurement |
| Does a point mutation in SLC18A3 alter transport kinetics? | Point-mutation knock-in cell lines expressing mutant VAChT |
| Can acetylcholine transport be monitored in live cells? | Tagged knock-in of SLC18A3 with fluorescent protein for imaging |
| What genes regulate acetylcholine transport in cancer? | CRISPR library screening in lung cancer cell lines |
How to Study the acetylcholine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Vesicular transport assay | Active uptake of acetylcholine into vesicles | Measuring VAChT function and kinetics |
| Fluorescent imaging | Real-time transport and vesicle dynamics | Live-cell visualization of acetylcholine transport |
| CRISPR library screening | Genes regulating acetylcholine transport | Discovery of novel transport modulators |
| RNA-seq | Expression of transporters and related genes | Tissue-specific and disease-related profiling |
| Proteomics | Protein levels of transporters | Validation of expression changes |
| Radioligand binding | Transporter binding affinity | Pharmacological characterization |
| Acetylcholine quantification | Extracellular and intracellular acetylcholine levels | Assessing transport activity in cells |
| Electrophysiology | Cholinergic synaptic transmission | Functional readout of transport and release |
Vesicular transport assays
Vesicular transport assays using isolated synaptic vesicles or reconstituted proteoliposomes are used to measure the active transport of acetylcholine by VAChT. These assays typically monitor the uptake of radiolabeled acetylcholine in the presence of a proton gradient. They are essential for determining transport kinetics and inhibitor sensitivity.
Fluorescent imaging of acetylcholine transport
Genetically encoded fluorescent sensors or tagged transporters can be used to visualize acetylcholine transport in live cells. Tagged knock-in of SLC18A3 with a fluorescent protein allows real-time tracking of vesicular dynamics. This approach is valuable for studying transport in neurons and non-neuronal cells.
CRISPR screening for transport regulators
CRISPR library screening can identify genes that regulate acetylcholine transport in cancer and other cell types. Pooled screens with readouts such as acetylcholine levels or transporter activity can uncover novel modulators. This method is powerful for discovering therapeutic targets.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can quantify the expression of acetylcholine transporters and related genes across tissues and disease states. These methods help identify co-regulated genes and pathways. They are often combined with functional transport assays to validate findings.
How CRISPR Can Be Used to Study GO:0015870 acetylcholine transport
Knockout
CRISPR knockout of SLC18A3 (VAChT) or SLC22A4 can abolish acetylcholine transport, providing a clean model to study its loss-of-function effects. Knockout cell lines are used to measure vesicular transport deficits and downstream signaling changes. These models are essential for validating the causal role of specific transporters.
Point Mutation
Point mutations in SLC18A3 can be introduced to mimic human variants or to dissect transport mechanism. For example, mutations in the proton translocation pathway can uncouple transport from the gradient. Point-mutation cell lines help determine the impact of specific residues on acetylcholine transport.
Knock-in
Knock-in of tagged SLC18A3 or SLC22A4 allows visualization and affinity purification of the transporters. Tagged knock-in models are valuable for tracking transporter localization and dynamics in live cells. They also enable proteomic identification of interacting proteins.
Overexpression
Overexpression of SLC18A3 or SLC22A4 can enhance acetylcholine transport and increase vesicular stores. Overexpression models are used to study gain-of-function effects and to screen for transport inhibitors. They are also useful for producing large amounts of transporter protein for structural studies.
How EDITGENE Supports acetylcholine transport Research
Researchers studying acetylcholine transport-related genes often need to determine whether a candidate gene is causally involved in vesicular storage, plasma membrane transport, or non-neuronal cholinergic signaling. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for acetylcholine transport research.
Frequently Asked Questions About acetylcholine transport
What is acetylcholine transport?
Acetylcholine transport is the directed movement of acetylcholine into, out of, or within a cell by transporters or pores, as defined by GO:0015870.
What genes are involved in acetylcholine transport?
Key genes include SLC18A3 (VAChT), SLC22A4 (OCTN1), SLC5A7 (CHT1), CHAT, and ACHE.
How is acetylcholine transported into synaptic vesicles?
The vesicular acetylcholine transporter (VAChT, SLC18A3) actively pumps acetylcholine into synaptic vesicles using a proton gradient.
What is the role of SLC22A4 in acetylcholine transport?
SLC22A4 (OCTN1) mediates the transport of acetylcholine and acetylcarnitine in peritoneal and other cells.
Is acetylcholine transport involved in cancer?
Yes, acetylcholine transport and signaling contribute to lung cancer progression and breast cancer pre-metastatic niche formation.
What diseases are associated with defective acetylcholine transport?
Defects can lead to neuromuscular disorders, neurodegenerative diseases, and gastric secretion disorders.
How can I study acetylcholine transport in the lab?
Common methods include vesicular transport assays, fluorescent imaging, CRISPR screening, and RNA-seq.
What is the difference between VAChT and CHT1?
VAChT packages acetylcholine into vesicles, while CHT1 takes up choline for acetylcholine synthesis.
Can CRISPR be used to study acetylcholine transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study transporters like SLC18A3 and SLC22A4.
What is the GO term for acetylcholine transport?
The Gene Ontology term is GO:0015870, acetylcholine transport, a biological process.
Conclusion
Acetylcholine transport (GO:0015870) is a fundamental biological process that enables cholinergic neurotransmission and non-neuronal signaling. The vesicular acetylcholine transporter (VAChT) and plasma membrane transporters such as SLC22A4 are key mediators of this process, with roles in synaptic storage, cancer progression, and gastric secretion. Understanding the molecular mechanisms and regulation of acetylcholine transport is essential for developing therapies for neurological, muscular, and oncological diseases. Continued research using CRISPR models and advanced imaging will further elucidate the complexities of this transport system.
References
- 1. Parsons SM et al.. 1993. Acetylcholine transport, storage, and release.. Int Rev Neurobiol 35:279-390 PMID: 8463062
- 2. Parsons SM. 2000. Transport mechanisms in acetylcholine and monoamine storage.. FASEB J 14(15):2423-34 PMID: 11099460
- 3. Pochini L et al.. 2016. Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter.. Biochim Biophys Acta 1858(4):653-60 PMID: 26724204
- 4. Pan J et al.. 2023. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis.. J Exp Clin Cancer Res 42(1):255 PMID: 37773152
- 5. Schubert ML. 2014. Gastric secretion.. Curr Opin Gastroenterol 30(6):578-82 PMID: 25211241
- 6. Michel V et al.. 2006. Choline transport for phospholipid synthesis.. Exp Biol Med (Maywood) 231(5):490-504 PMID: 16636297
- 7. Varoqui H et al.. 1996. Active transport of acetylcholine by the human vesicular acetylcholine transporter.. J Biol Chem 271(44):27229-32 PMID: 8910293
- 8. Friedman JR et al.. 2019. Acetylcholine signaling system in progression of lung cancers.. Pharmacol Ther 194:222-254 PMID: 30291908
